| Elizabeth Ostoja, MSN, FNP | |
|
1976 Lime Kiln Rd, Green Bay, WI 54311-4417 | |
| (920) 445-7377 | |
| (920) 592-9479 |
| Full Name | Elizabeth Ostoja |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1976 Lime Kiln Rd, Green Bay, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003006099 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 7668 (Wisconsin) | Primary |
| Entity Name | Marshfield Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952347981 PECOS PAC ID: 2264345206 Enrollment ID: O20031106000590 |
News Archive
Hospira today announced that Inflectra (infliximab), the first monoclonal antibody (mAb) biosimilar therapy, has been registered in Australia. This registration paves the way for the Federal Government to reduce the cost of some of the most expensive medicines on the Pharmaceutical Benefits Scheme (PBS).
This week, the Global Fund to Fight AIDS, Tuberculosis and Malaria gathered representatives from donor and implementing countries in Brussels, Belgium, to formally launch its 2014-2016 replenishment process.
At a time when the U.S. spends more than double what other countries spend for medical care - $6,697 per capita in 2005 - a new Commonwealth Fund seven-nation survey finds that U.S. patients are more likely to report experiencing medical errors, to go without care because of costs, and to say that the health care system needs to be rebuilt completely.
Findings of a preliminary study published in The Lancet Respiratory Medicine suggest that a patient's own bone-marrow stromal (stem) cells could be used to treat multidrug-resistant (MDR) and extensively-drug (XDR) tuberculosis.
In a study with the longest follow-up to date of patients with a high-risk form of heart disease known as left main coronary artery disease (LMCAD), researchers found no significant differences in rates of death, heart attack or stroke between patients who were treated with a stent and those who underwent heart bypass surgery.
› Verified 5 days ago
| Entity Name | Vpa Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659484657 PECOS PAC ID: 9234041948 Enrollment ID: O20040322000734 |
News Archive
Hospira today announced that Inflectra (infliximab), the first monoclonal antibody (mAb) biosimilar therapy, has been registered in Australia. This registration paves the way for the Federal Government to reduce the cost of some of the most expensive medicines on the Pharmaceutical Benefits Scheme (PBS).
This week, the Global Fund to Fight AIDS, Tuberculosis and Malaria gathered representatives from donor and implementing countries in Brussels, Belgium, to formally launch its 2014-2016 replenishment process.
At a time when the U.S. spends more than double what other countries spend for medical care - $6,697 per capita in 2005 - a new Commonwealth Fund seven-nation survey finds that U.S. patients are more likely to report experiencing medical errors, to go without care because of costs, and to say that the health care system needs to be rebuilt completely.
Findings of a preliminary study published in The Lancet Respiratory Medicine suggest that a patient's own bone-marrow stromal (stem) cells could be used to treat multidrug-resistant (MDR) and extensively-drug (XDR) tuberculosis.
In a study with the longest follow-up to date of patients with a high-risk form of heart disease known as left main coronary artery disease (LMCAD), researchers found no significant differences in rates of death, heart attack or stroke between patients who were treated with a stent and those who underwent heart bypass surgery.
› Verified 5 days ago
| Entity Name | Mchs Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093221434 PECOS PAC ID: 5698071173 Enrollment ID: O20180208000096 |
News Archive
Hospira today announced that Inflectra (infliximab), the first monoclonal antibody (mAb) biosimilar therapy, has been registered in Australia. This registration paves the way for the Federal Government to reduce the cost of some of the most expensive medicines on the Pharmaceutical Benefits Scheme (PBS).
This week, the Global Fund to Fight AIDS, Tuberculosis and Malaria gathered representatives from donor and implementing countries in Brussels, Belgium, to formally launch its 2014-2016 replenishment process.
At a time when the U.S. spends more than double what other countries spend for medical care - $6,697 per capita in 2005 - a new Commonwealth Fund seven-nation survey finds that U.S. patients are more likely to report experiencing medical errors, to go without care because of costs, and to say that the health care system needs to be rebuilt completely.
Findings of a preliminary study published in The Lancet Respiratory Medicine suggest that a patient's own bone-marrow stromal (stem) cells could be used to treat multidrug-resistant (MDR) and extensively-drug (XDR) tuberculosis.
In a study with the longest follow-up to date of patients with a high-risk form of heart disease known as left main coronary artery disease (LMCAD), researchers found no significant differences in rates of death, heart attack or stroke between patients who were treated with a stent and those who underwent heart bypass surgery.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Ostoja, MSN, FNP Po Box 22487, Green Bay, WI 54305-2487 Ph: (920) 445-7226 | Elizabeth Ostoja, MSN, FNP 1976 Lime Kiln Rd, Green Bay, WI 54311-4417 Ph: (920) 445-7377 |
News Archive
Hospira today announced that Inflectra (infliximab), the first monoclonal antibody (mAb) biosimilar therapy, has been registered in Australia. This registration paves the way for the Federal Government to reduce the cost of some of the most expensive medicines on the Pharmaceutical Benefits Scheme (PBS).
This week, the Global Fund to Fight AIDS, Tuberculosis and Malaria gathered representatives from donor and implementing countries in Brussels, Belgium, to formally launch its 2014-2016 replenishment process.
At a time when the U.S. spends more than double what other countries spend for medical care - $6,697 per capita in 2005 - a new Commonwealth Fund seven-nation survey finds that U.S. patients are more likely to report experiencing medical errors, to go without care because of costs, and to say that the health care system needs to be rebuilt completely.
Findings of a preliminary study published in The Lancet Respiratory Medicine suggest that a patient's own bone-marrow stromal (stem) cells could be used to treat multidrug-resistant (MDR) and extensively-drug (XDR) tuberculosis.
In a study with the longest follow-up to date of patients with a high-risk form of heart disease known as left main coronary artery disease (LMCAD), researchers found no significant differences in rates of death, heart attack or stroke between patients who were treated with a stent and those who underwent heart bypass surgery.
› Verified 5 days ago
Tammy Ann Motquin, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 744 S Webster Ave, Green Bay, WI 54301 Phone: 920-445-7226 | |
Mary C Fox, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3237 Voyager Dr, Green Bay, WI 54311 Phone: 920-468-8288 | |
Mrs. Kristen Kay Lampe, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 720 S Van Buren St, Suite 201, Green Bay, WI 54301 Phone: 920-433-7488 | |
Nicole L Lowe, APNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2253 W Mason St, Green Bay, WI 54303 Phone: 920-327-7300 Fax: 920-327-7348 | |
Mr. Cristian A Vasiliev, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 923 Eliza St, Green Bay, WI 54301 Phone: 920-965-4800 | |
Linda Susan Haen, FNPC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2641 Development Drive, Green Bay, WI 54311 Phone: 920-338-6868 Fax: 920-338-6869 |